Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Harrow Inc (NQ: HROW )

45.64 +0.58 (+1.29%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Harrow Inc

< Previous 1 2 3 4 5 6 7 Next >
Harrow Health Provides $13.5 Million Senior Secured Loan to Melt Pharmaceuticals
From Harrow Health, Inc.
Via Business Wire
Harrow Health Acquires Japan-Approved Ophthalmic Injection For Undisclosed Sum
For an undisclosed amount, Harrow Health Inc (NASDAQ: HROW) has agreed to acquire MAQ-100 U.S. and Canadian commercial rights from Wakamoto... 
Via Benzinga
Harrow Health Acquires Ophthalmic Surgical Drug Candidate From Wakamoto Pharmaceutical Co., Ltd.
From Harrow Health, Inc.
Via Business Wire
Harrow Health to Participate in Two Upcoming Virtual Investor Conferences
From Harrow Health, Inc.
Via Business Wire
Earnings Scheduled For August 10, 2021
Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:... 
Via Benzinga
Earnings Scheduled For May 11, 2021
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is... 
Via Benzinga
Harrow Health: Q2 Earnings Insights
Shares of Harrow Health (NASDAQ:HROW) were flat after the company reported Q2 results. Quarterly Results Earnings per share decreased 1000.00% year over year to ($0.11),... 
Via Benzinga
Harrow Health Announces Second Quarter 2021 Financial Results
From Harrow Health, Inc.
Via Business Wire
Harrow Health Acquires Patented Ophthalmic Surgical Drug Candidate from Sintetica
From Harrow Health, Inc.
Via Business Wire
NovaBay Pharmaceuticals Partners with Harrow Health’s ImprimisRx® to Promote Prescription Avenova
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Celldex Therapeutics (NASDAQ:CLDX) stock rose 41.93% to $46.0 during Monday's pre-market session. The company's market cap stands at $1.8 billion. 180 Life... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 2, 2021
Upgrades According to Deutsche Bank, the prior rating for Encompass Health Corp (NYSE: 
Via Benzinga
Harrow Health: Return On Capital Employed Insights
Harrow Health (NASDAQ:HROW) posted a 7.77% decrease in earnings from Q4. Sales, however, increased by 5.81% over the previous quarter to $15.44 million. Despite the increase in... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 88% to settle at $36.08 on Thursday. Urban One, Inc. (NASDAQ: UONE) gained 59.1% to close at $9.56. Urban... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Enveric Biosciences (NASDAQ:ENVB)... 
Via Benzinga
62 Biggest Movers From Yesterday
Gainers Curis, Inc. (NASDAQ: CRIS) shares surged 65.5% to settle at $16.27 on Wednesday in reaction to updated data from its ongoing open-label, single-arm, Phase 1/2 study of CA... 
Via Benzinga
Mid-Afternoon Market Update: Dow Dips 500 Points; Ra Medical Systems Shares Spike Higher
Toward the end of trading Wednesday, the Dow traded down 1.47% to 33,769 while the NASDAQ fell 2.21% to 13,093.66. The S&P also fell, dropping 1.66% to 4,083.31. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Mid-Day Market Update: Array Technologies Drops Following Downbeat Earnings; Harrow Health Shares Climb
Midway through trading Wednesday, the Dow traded down 0.79% to 33,998.86 while the NASDAQ fell 1.59% to 13,177.20. The S&P also fell, dropping 1.03% to 4,109.52. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 76% to $5.84 after the company reported better-than-expected Q1 results. Lucira Health, Inc. (NASDAQ: LHDX) gained... 
Via Benzinga
Recap: Harrow Health Q1 Earnings
Shares of Harrow Health (NASDAQ:HROW) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 102.00% year over... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.